Reuters - Video

Edition: US | UK | IN | CN | JP

video Business

$59bln: What it costs to become a drugs player

Wednesday, December 05, 2018 - 01:07

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire, creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt. Julian Satterthwaite reports.

▲ Hide Transcript

View Transcript

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire, creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt. Julian Satterthwaite reports.

Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code

$59bln: What it costs to become a drugs player

Wednesday, December 05, 2018 - 01:07